Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Impact of extended interval dosing of immune checkpoint inhibitors in lung cancer patients during the COVID-19 pandemic.

Marie Veron,Thomas Pierret,Maurice Pérol,François Bettega,Justin Benet,Natacha Denis,Denis Moro-Sibilot,Aurélie Swalduz,Anne-Claire Toffart

Respiratory medicine and research（2023）

Cited 0|Views15
No score
Abstract
Our study suggests that EI dosing of ICIs did not affect toxicity and overall survival in lung cancer patients.
More
Translated text
Key words
COVID 19-pandemic,Immune checkpoint inhibitors,Immune-related toxicity,Lung cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined